Citation Impact
Citing Papers
Mechanisms of Viral Membrane Fusion and Its Inhibition
2001
Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
2010
Directed Evolution Mimics Allosteric Activation by Stepwise Tuning of the Conformational Ensemble
2018 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Direct NMR observation of a substrate protein bound to the chaperonin GroEL
2005 Nobel
Catalysis by dihydrofolate reductase and other enzymes arises from electrostatic preorganization, not conformational motions
2011 StandoutNobel
A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1
2001
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Vector-Mediated Antibody Gene Transfer for Infectious Diseases
2015
Dynamic personalities of proteins
2007 StandoutNature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate
2005
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site
2009
Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies
2007
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
2016
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Membrane Fusion
2003 StandoutNobel
Neutralizing antiviral antibody responses
2001
Strategies for designing and optimizing new generation vaccines
2001
Progress on new vaccine strategies against chronic viral infections
2004
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense
2011 StandoutNobel
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Immunopathogenesis and immunotherapy in AIDS virus infections
2003
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
2009
Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity
2006
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses
2011
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Structural Analysis of the Epitope of the Anti-HIV Antibody 2F5 Sheds Light into Its Mechanism of Neutralization and HIV Fusion
2003
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models
2008
SARS-CoV-2 vaccines in development
2020 StandoutNature
Total Synthesis of Siomycin A: Construction of Synthetic Segments
2008
Vaccines for the prevention of HIV-1 disease
2001
Structure and Dynamics of a Processive Brownian Motor: The Translating Ribosome
2010 StandoutNobel
Iron Catalysis in Organic Synthesis
2015 Standout
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Stereoselective Organic Reactions in Water
2002 Standout
A systems approach to cancer therapy
1996
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Dynamical Contributions to Enzyme Catalysis: Critical Tests of A Popular Hypothesis
2006 StandoutNobel
Synthesis of Nitroalkenes Involving a Cooperative Catalytic Action of Iron(III) and Piperidine: A One‐Pot Synthetic Strategy to 3‐Alkylindoles, 2H‐Chromenes and N‐Arylpyrrole
2013
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120
2002
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
2011 StandoutScienceNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
2004
Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen
2001
Polymeric Systems for Controlled Drug Release
1999 Standout
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Construction of Carbocyclic Arrays Containing Nitrogen via Intramolecular Imino Diels−Alder Reactions in Polar Media. A Comparative Study: 5.0 M Lithium Perchlorate−Diethyl Ether versus Water
1999
Recent Advances in Asymmetric Catalytic Metal Carbene Transformations
1998 Standout
A Bispecific Antibody Composed of a Nonneutralizing Antibody to the gp41 Immunodominant Region and an Anti-CD89 Antibody Directs Broad Human Immunodeficiency Virus Destruction by Neutrophils
2008
Anti-HIV B Cell Lines as Candidate Vaccine Biosensors
2012
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Induction of Mucosal and Systemic Neutralizing Antibodies against Human Immunodeficiency Virus Type 1 (HIV-1) by Oral Immunization with Bovine Papillomavirus-HIV-1 gp41 Chimeric Virus-Like Particles
2004
Unmutated Immunoglobulin M Can Protect Mice from Death by Influenza Virus Infection
2003 StandoutNobel
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120
2002
Antibodies in HIV-1 Vaccine Development and Therapy
2013 Science
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody
2013
A Stereospecific Access to Allylic Systems Using Rhodium(II)−Vinyl Carbenoid Insertion into Si−H, O−H, and N−H Bonds
1997
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Microwave-Assisted Synthesis in Water as Solvent
2007 Standout
The oral mucosa immune environment and oral transmission of HIV /SIV
2013
Immunologic Control of HIV-1
2002
Solid-Phase Synthesis of Polyamine Toxin Analogues: Potent and Selective Antagonists of Ca2+-Permeable AMPA Receptors
2002
Organic Reactions in Aqueous Media with a Focus on Carbon−Carbon Bond Formations: A Decade Update
2005 Standout
Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors
2007
Electrostatic Basis for Enzyme Catalysis
2006 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Advances in Synthetic Applications of Hypervalent Iodine Compounds
2016 Standout
Identification of a New Endogenous Metabolite and the Characterization of Its Protein Interactions through an Immobilization Approach
2008 StandoutNobel
Immunoglobulin G (IgG) and IgA, but also Nonantibody Factors, Account for In Vitro Neutralization of Human Immunodeficiency Virus (HIV) Type 1 Primary Isolates by Serum and Plasma of HIV-Infected Patients
2001 StandoutNobel
Viral Persistence: HIV's Strategies of Immune System Evasion
2002
Containment of Simian Immunodeficiency Virus Infection in Vaccinated Macaques: Correlation with the Magnitude of Virus-Specific Pre- and Postchallenge CD4+ and CD8+ T Cell Responses
2002
Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope
2009
A Chemoselective Hydrogenation of the Olefinic Bond of α,β‐Unsaturated Carbonyl Compounds in Aqueous Medium under Microwave Irradiation
2006
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
GP120: Biologic Aspects of Structural Features
2001
Progress on new vaccine strategies against chronic viral infections
2004
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Macromolecular systems for chemotherapy and magnetic resonance imaging
1996
Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life
2002
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Synthesis of 4,5-Dianilinophthalimide and Related Analogues for Potential Treatment of Alzheimer's Disease via Palladium-Catalyzed Amination
2005
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
The Long Third Complementarity-Determining Region of the Heavy Chain Is Important in the Activity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5
2004
Structure, Dynamics, and Catalytic Function of Dihydrofolate Reductase
2004
Progress toward active or passive HIV-1 vaccination
2016
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Mechanisms of Neonatal Mucosal Antibody Protection
2006
RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design
2011 StandoutNobel
An Improved Preparation ofN2‐tert‐Butoxycarbonyl‐ andN2‐Benzyloxy‐carbonyl‐(S)‐2,4‐diaminobutanoic Acids
2004
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120
2002
Glyco-seek: Ultrasensitive Detection of Protein-Specific Glycosylation by Proximity Ligation Polymerase Chain Reaction
2016 StandoutNobel
Works of Joel E. Wright being referenced
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection
2000
2,4-Diaminothieno[2,3-d]pyrimidine analogs of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase
1993
Induction of a 70kD protein associated with the selective cytotoxicity of beta-carotene in human epidermal carcinoma
1990
Analogues of Nα-(4-Amino-4-deoxypteroyl)-Nδ-hemiphthaloyl-l -ornithine (PT523) Modified in the Side Chain: Synthesis and Biological Evaluation
1997
N.epsilon.-[[2-(Trimethylsilyl)ethoxy]carbonyl] derivatives of tri-L-lysine and tetra-L-lysine as potential intermediates in the block polymer synthesis of macromolecular drug conjugates
1989
NMR Solution Structure of the Antitumor Compound PT523 and NADPH in the Ternary Complex with Human Dihydrofolate Reductase
1997
N.omega.-Alkoxycarbonylation of .alpha.,.omega.-diamino acids with 2-(trimethylsilyl)ethyl 4-nitrophenyl carbonate
1983